Specialty Pharmacy

Overall 3-year survival in patients with advanced melanoma taking pembrolizumab was 40%.

Study finds link between marital bliss and greater risk of diabetes development.

Study finds need for updated pricing system for hepatitis C virus medications.

Thiazole benzensulfonamides (TZB) show useful anticancer properties.

Alcohol found to affect biologic mechanisms that raise the risk of cancer.

Hsp90 inhibitors target and inactivate a mechanism that cancer cells use to evade standard treatments.

Linagliptin and metformin hydrochloride extended-release tablets approved for adults with type 2 diabetes.

Family caregivers of patients with terminal cancers could benefit from early palliative care.

Growing use of payer rebates among drivers of US drug spending increase.

The critical beginning stages of HIV have been found to be less symptomatic than previously thought.

Genetic variant in the chromosome 5q11 affects development of multiple sclerosis.

HA15 causes melanoma cell death, but does not affect healthy cells.

Ninety-three percent of B-cell acute lymphoblastic leukemia patients treated went into remission in small study.

Top news of the day from across the health care landscape.

Improved cancer detection rates and a reduced recall rates can be enhanced.

Ocaliva approved in combination with ursodeoxycholic acid (UDCA) or as a monotherapy for adults who can’t tolerate UDCA.

Researchers evaluate patient preferences in the treatment of rheumatoid arthritis.

Good bacteria prevented from working effectively in some inflammatory bowel disease patients.

Growing number of patients with life-threatening liver disease being removed from transplant waiting lists.

Long-term exposure to particulate matter increases mortality risk from cancer.

New method may help overcome barriers in patient recruitment to clinical trials.

Fasting-like diet shows promise treating autoimmune diseases in small study.

Top news of the day from across the healthcare landscape.

Patients with multiple myeloma receiving ASCT showed a 10% increase in tumor cell reduction.

Fluciclovine F 18 (Axumin) is a radioactive diagnostic agent that can be used to detect recurring prostate cancer.

Researchers evaluate why HIV-infected individuals have lower magnitude responses to flu vaccines.

Out-of-pocket limits significantly higher under ACA bronze and silver plans than with employer-based plans.

CRISPR/Cas9 gene editing system shows promise eliminating HIV.

Treatment delays prevent tight blood sugar control in type 2 diabetes patients.

The underlying mechanisms of the immune system may lead to new treatments for COPD and lupus.